We report a Norwegian-Vietnamese girl aged 6 years and 3 months with NF2 who presented with multiple intra-dermal schwannomas, including one on the left buttock evident at birth. Pregnancy, delivery, and family history were unremarkable. By age 1 year and 10 months, she had eight nodular skin-colored tumors at various sites ranging in diameter from approximately one to three cm (Figures 1 and 2) . Two separate tumors were biopsied; one was reported histologically as a plexiform schwannoma/neurofibroma and the other as a schwannoma. A clinical diagnosis of NF2 was made at age 2 years and 11 months and confirmed molecularly at age 3 years and 4 months. Ophthalmological exam was normal at age two and a half years. Cerebral and spinal MRI scans at the same age were initially 
To the Editor:
Bilateral vestibular schwannomas, presenting before age 30 years and associated with tinnitus, hearing loss, and balance problems, are the hallmark of neurofibromatosis type 2 (NF2). Additional features of this rare genetic tumor predisposition syndrome include schwannomas involving other cranial, spinal, and peripheral nerves, ependymomas, meningiomas, posterior subcapsular lens opacities, and mononeuropathies. Diagnostic delay in children is common for two reasons:
(i) Pediatricians may not be familiar with NF2 because the average age of onset is 18-24 years (Evans, 2011) , (ii) in children, the first disease manifestations are often different than in adults and precede the development of symptomatic vestibular schwannomas by several years. Pediatric presentations of NF2 include single or multiple intradermal schwannomas, meningiomas, lower limb hypotrophy, facial nerve neuropathy, hyperpigmented dermal plaques, and lenticular lesions (Evans et al., 1999) Analysis of NF2, the only gene known to be associated with NF2, can usually confirm a clinical suspicion of NF2 in children. Analysis of tumor DNA is often necessary in simplex cases.
We report a Norwegian-Vietnamese girl aged 6 years and 3 months with NF2 who presented with multiple intra-dermal schwannomas, including one on the left buttock evident at birth. Pregnancy, delivery, and family history were unremarkable. By age 1 year and 10 months, she had eight nodular skin-colored tumors at various sites ranging in diameter from approximately one to three cm (Figures 1 and 2) . Two separate tumors were biopsied; one was reported histologically as a plexiform schwannoma/neurofibroma and the other as a schwannoma. A clinical diagnosis of NF2 was made at age 2 years and 11 months and confirmed molecularly at age 3 years and 4 months. Ophthalmological exam was normal at age two and a half years. Cerebral and spinal MRI scans at the same age were initially There are few reports of NF2 with onset before 1 year of age (Ruggieri et al., 2013) . NF2 manifesting this early often has a nonclassical presentation and course. Children with NF2 usually come to medical attention because of ocular, subtle skin or neurological features (Ruggieri et al., 2005) . Constitutional NF2 mutations are a frequent cause of meningioma in children (Evans, Watson, King, Wallace, & Baser, 2005 ). An initial presentation with multiple schwannomas raises the differential diagnosis of schwannomatosis.
However, the intra-dermal localization of schwannomas in this child is characteristic of NF2 and has not been described in schwannomatosis (MacCollin et al., 2005) .
Mosaicism is present in over 30% of simplex cases of NF2 (Evans et al., 2007) Genotype-phenotype associations are well established.
Whole gene deletions account for ∼5-10% of germline mutations (Smith et al., 2016) . Large deletions have a variable phenotype: some give rise to unexpectedly mild phenotypes, but in general they are the second most deleterious type of constitutional mutation (Hexter et al., 2015) . The most severe phenotype is associated with truncating nonsense and frameshift mutations. Nonsense mutations are more common than frameshift changes in the germline, and this relationship is reversed in somatic mosaicism (Evans, Maher et al., 2005) Missense mutations are associated with a much lower risk of mortality and a milder clinical phenotype (Hexter et al., 2015) .
The severe and early presentation of mosaic NF2 in this child is unusual. Only 10% of NF2 cases have more than 10 cutaneous lesions (Evans et al., 1992) . We speculate that a second hit, a large chromosome 22 deletion, likely occurred during foetal development.
Our patient's unusual presentation contributed to slight diagnostic delay. Management issues in severe pediatric NF2 are complex.
Surveillance, medical treatment, and surgical intervention must be tailored to the needs of the individual child (Ruggieri et al., 2016) .
Children with NF2 should be managed by, and in co-operation with, a multidisciplinary specialist team familiar with the disease (Ruggieri et al., 2016) .
ACKNOWLEDGMENTS
We are grateful to the parents for their active and generous participation in the development of this report.
CONFLICTS OF INTEREST
None.
